• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diagnosis and management of new cardiovascular risk factors.

作者信息

Cullen P, von Eckardstein A, Assmann G

机构信息

Institute of Clinical Chemistry and Laboratory Medicine, University of Münster, Germany.

出版信息

Eur Heart J. 1998 Nov;19 Suppl O:O13-9.

PMID:9857944
Abstract

Independent risk factors for coronary heart disease (CHD) can best be identified by means of long-term prospective epidemiological studies. These factors should not be viewed in isolation, but as part of a complex governing a person's global risk of CHD. In the Münster Heart Study (PROCAM), 8-year follow up of a cohort of middle-aged men has led to the identification of nine variables which independently contribute to CHD risk: age, smoking history, personal history of angina pectoris, family history of myocardial infarction (MI), presence of diabetes mellitus, systolic blood pressure and the levels of low density lipoprotein (LDL) cholesterol, high density lipoprotein cholesterol and triglyceride. An algorithm based on these risk factors may be used to calculate an individual's risk of fatal or non-fatal MI and is available in interactive fashion on the website of the International Task Force for Prevention of Coronary Heart Disease at www.chd-taskforce.com. Treatment goals for LDL cholesterol depend on a person's level of risk: for persons with a small increase in risk 160 mg x dl(-1), for those with a moderate increase in risk 135 mg x dl(-1) and for those at high risk, including those with a history of CHD (secondary prevention) 100 mg x dl(-1). Intervention trials indicate that lowering of LDL cholesterol for 5 years produces much of the benefit predicted from the epidemiological data. The place of newer risk markers such as Lp(a), homocysteine, and parameters of clotting and inflammation in risk prediction and management remains to be determined.

摘要

相似文献

1
Diagnosis and management of new cardiovascular risk factors.
Eur Heart J. 1998 Nov;19 Suppl O:O13-9.
2
Lipoproteins and cardiovascular risk--from genetics to CHD prevention.脂蛋白与心血管疾病风险——从基因到冠心病预防
Eur Heart J. 1998 Apr;19 Suppl C:C5-11.
3
A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.老年人血脂水平与冠心病的长期随访研究
Chin Med J (Engl). 2004 Feb;117(2):163-7.
4
[Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].早期缺血性心脏病患者以及有缺血性心脏病家族史的患者体内脂蛋白(a)水平升高。
Minerva Med. 1999 May-Jun;90(5-6):151-8.
5
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).冠心病患者中提高高密度脂蛋白胆固醇的临床获益与血清低密度脂蛋白胆固醇水平的关系(来自苯扎贝特预防心肌梗死试验)
Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.
6
The Münster Heart Study (PROCAM). Results of follow-up at 8 years.明斯特心脏研究(PROCAM)。8年随访结果。
Eur Heart J. 1998 Feb;19 Suppl A:A2-11.
7
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.2型糖尿病与冠心病风险:PROCAM研究10年随访结果
Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):230-6. doi: 10.1097/HJR.0b013e3280142037.
8
Prediction of first events of coronary heart disease and stroke with consideration of adiposity.考虑肥胖因素对冠心病和中风首发事件的预测
Circulation. 2008 Jul 8;118(2):124-30. doi: 10.1161/CIRCULATIONAHA.108.772962.
9
New and classical risk factors--the Münster heart study (PROCAM).新的和传统的危险因素——明斯特心脏研究(PROCAM)。
Eur J Med Res. 1997 Jun 16;2(6):237-42.
10
Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.载脂蛋白B、低密度脂蛋白胆固醇与男性冠心病的长期风险
Am J Cardiol. 2006 Apr 1;97(7):997-1001. doi: 10.1016/j.amjcard.2005.10.060. Epub 2006 Feb 13.

引用本文的文献

1
Vall d'Hebron Risk Score II for myocardial infarction and cardiac death.瓦尔登霍伦风险评分 II 与心肌梗死和心脏死亡。
Open Heart. 2023 Nov;10(2). doi: 10.1136/openhrt-2023-002431.
2
Lipid profiles of persons with paraplegia and tetraplegia: sex differences.截瘫和四肢瘫患者的血脂谱:性别差异
J Spinal Cord Med. 2008;31(3):285-9. doi: 10.1080/10790268.2008.11760724.
3
Involuntary job loss as a risk factor for subsequent myocardial infarction and stroke: findings from the Health and Retirement Survey.非自愿失业作为后续心肌梗死和中风的风险因素:来自健康与退休调查的结果。
Am J Ind Med. 2004 May;45(5):408-16. doi: 10.1002/ajim.20004.
4
A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials.一项基于随机对照试验的个体患者数据,用于预测血压升高的成年人心血管疾病死亡风险的评分。
BMJ. 2001 Jul 14;323(7304):75-81. doi: 10.1136/bmj.323.7304.75.
5
Current, new and future treatments in dyslipidaemia and atherosclerosis.血脂异常和动脉粥样硬化的当前、新型及未来治疗方法
Drugs. 2000 Jul;60(1):55-93. doi: 10.2165/00003495-200060010-00005.